# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 516 results.
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
Status: Recruiting
Last Changed: Jun 26, 2019
First Received: May 03, 2017
Disease(s): Sarcoma
Intervention(s): Pazopanib, Irinotecan, Temozolomide
Locations: UCSF Benioff Children's Hospital, Oakland, Oakland, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
A Study of sEphB4-HSA in Kaposi Sarcoma
Status: Not yet recruiting
Last Changed: Oct 01, 2019
First Received: Jun 20, 2019
Disease(s): Kaposi Sarcoma
Intervention(s): sEphB4-HSA
Locations: AIDS Healthcare Foundation, Beverly Hills, California, United States
UT Southwestern Medical Center, Dallas, Texas, United States
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Mar 10, 2017
Disease(s): Sarcoma
Intervention(s): PET/MR
Locations: UNC-Chapel Hill, Chapel Hill, North Carolina, United States
A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall
Status: Recruiting
Last Changed: Feb 06, 2020
First Received: Mar 28, 2013
Disease(s): Soft Tissue Sarcoma
Intervention(s): proton radiation, surgery (wide local excision; limb preservation surgery)
Locations: Loma Linda University Medical Center / James M. Slater Proton Treatment Center, Loma Linda, California, United States
A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma
Status: Recruiting
Last Changed: Jul 11, 2019
First Received: May 02, 2018
Disease(s): Relapsed Ewing Sarcoma
Intervention(s): INCB059872
Locations: UCLA Jonsson Comprehensive Cancer, Los Angeles, California, United States
Mayo Clinic Jacksonville - PPDS, Jacksonville, Florida, United States
Columbia University Medical Center, New York, New York, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
... and 7 other locations.
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Mar 03, 2017
Disease(s): Sarcoma
Intervention(s): Talimogene Laherparepvec (T-VEC), Pembrolizumab
Locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States
Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma
Status: Not yet recruiting
Last Changed: Aug 22, 2019
First Received: Aug 22, 2019
Disease(s): Kaposi Sarcoma
Intervention(s): Talimogene laherparepvec
Locations: Service de Dermatologie Hopital Saint-Louis, Paris, France
Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)
Status: Recruiting
Last Changed: Oct 23, 2018
First Received: Jan 16, 2017
Disease(s): Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma
Intervention(s): No Intervention
Locations: Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria
Medizinische Universität Wien, Wien, Austria
HELIOS Klinikum Bad Saarow, Bad Saarow, Germany
HELIOS Klinikum Berlin Buch, Berlin, Germany
Klinikum Spandau, Berlin, Germany
... and 8 other locations.
Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
Status: Not yet recruiting
Last Changed: Jan 18, 2020
First Received: Sep 03, 2019
Disease(s): Sarcoma, Sarcoma Metastatic
Intervention(s): Olaparib, Trabectedin
Locations: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
MASCT-I Combined With PD1 and Apatinib in the Treatment of Tissue Sarcoma
Status: Not yet recruiting
Last Changed: Sep 19, 2019
First Received: Aug 30, 2019
Disease(s): Sarcoma
Intervention(s): MASCT-I,PD1 Antibody,Apatinib
Locations: Shanghai Sixth People's Hospital, Shanghai, Shanghai, China